Les HIV controllers : Une nouvelle entité évolutive de l'infection par le VIH ? = HIV controllers : a new evolutionary entrty of HIV infection?MARTINEZ, Valérie; AUTRAN, Brigitte.MS. Médecine sciences. 2008, Vol 24, Num 1, pp 7-9, issn 0767-0974, 3 p.Article

Tétramères et cellules CD8 spécifiques d'antigènes = Antigen-specific CD8 cells and MHC-peptide tetramersMOLLET, Lucile; AUTRAN, Brigitte.Hématologie (Montrouge). 2001, Vol 7, Num 4, pp 251-259, issn 1264-7527Article

The Role of Immunotherapy in the Treatment of HIVSAAG, Michael S; AUTRAN, Brigitte.AIDS (Supplement). 2001, Vol 15, Num 2, issn 1350-2840, 45 p.Serial Issue

Therapeutic vaccines for chronic infections : ImmunotherapyAUTRAN, Brigitte; CARCELAIN, Guislaine; COMBADIERE, Béhazine et al.Science (Washington, D.C.). 2004, Vol 305, Num 5681, pp 205-208, issn 0036-8075, 4 p.Article

Low-dose daily interleukin-2 immunotherapy : Accelerating immune restoration and expanding HIV-specific T-cell immunity without toxicitySMITH, Kendall A.AIDS (Supplement). 2001, Vol 15, Num 2, pp S28-S35, issn 1350-2840Article

Immune restoration and CD4+ T-cell function with antiretroviral therapiesLEDERMAN, Michael M.AIDS (Supplement). 2001, Vol 15, Num 2, pp S11-S15, issn 1350-2840Article

The potential role of interleukin-2 in HIVMITSUYASU, Ronald T.AIDS (Supplement). 2001, Vol 15, Num 2, pp S22-S27, issn 1350-2840Article

The impact of highly active antiretroviral therapy on HIV-specific immune functionSAAG, Michael S.AIDS (Supplement). 2001, Vol 15, Num 2, pp S4-S10, issn 1350-2840Article

RECONSTITUTION IMMUNITAIRE SOUS TRAITEMENTS ANTIRETROVIRAUX COMBINES AU COURS DE L'INFECTION PAR LE VIRUS DE L'IMMUNODEFICIENCE HUMAINE (VIH) = IMMUNE RECONSTITUTION DURING HIGHLY ACTIVE ANTIRETROVIRAL THERAPIES IN HIV-1 INFECTED PATIENTSLi, Taisheng; Autran, Brigitte.1999, 191 p.Thesis

Réponses T cytotoxiques au VIH et contrôle des fonctions de cytotoxicité exercé par les cellules CD8+CD57+ = Cytotoxic T cell responses specific for HIV and control of cytotoxic cell function mediated by CD8+CD57+ cellsAutran, Brigitte; Debre, Patrice.1992, 154 p.Thesis

The chemokine receptor CX3CR1 controls homing and anti-viral potencies of CD8 effector-memory T lymphocytes in HIV-infected patientsCOMBADIERE, Béhazine; FAURE, Sophie; AUTRAN, Brigitte et al.AIDS (London). 2003, Vol 17, Num 9, pp 1279-1290, issn 0269-9370, 12 p.Article

Therapeutic vaccines against HIV and cancers, 23-26 June 2002, Les Pensières, Veyrier-du-Lac, Annecy, FranceAUTRAN, Brigitte; FRIDMAN, Hervé; LOTZE, Michael et al.Vaccine. Supplement. 2002, Vol 20, issn 1359-5938, 91 p., 4Conference Proceedings

AIDS 2003: A Year in ReviewAUTRAN, Brigitte; COUNTINHO, Roel; LEVY, Jay et al.AIDS (Supplement). 2003, Vol 17, issn 1350-2840, 133 p., SUP4Serial Issue

Registration of clinical trialsLEVY, Jay A; AUTRAN, Brigitte; COUTINHO, Roel et al.AIDS (London). 2005, Vol 19, Num 2, issn 0269-9370, p. 105Article

Reconstitution immune sous HAART : Effet des traitements antirétroviraux combinés = Immune reconstitution in HAART: effects of combination antiretroviral therapiesCARCELAIN, Guislaine; AUTRAN, Brigitte; DEBRE, Patrice et al.Annales de l'Institut Pasteur. Actualités. 2000, Vol 11, Num 3, pp 39-47, issn 0924-4204Article

Cell permeabilization for the assessment of T lymphocyte polyfunctional capacityPAPAGNO, Laura; ALMEIDA, Jorge R; NEMES, Elisa et al.Journal of immunological methods. 2007, Vol 328, Num 1-2, pp 182-188, issn 0022-1759, 7 p.Article

Virus-host interactions: role of HIV proteins vif, tat, and revSTREBEL, Klaus.AIDS (Supplement). 2003, Vol 17, pp S25-S34, issn 1350-2840, SUP4Article

Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants, by Dowling et alHOGG, Robert S.AIDS (Supplement). 2003, Vol 17, pp S125-S127, issn 1350-2840, SUP4Article

Apoptosis of immune cells in the tumor microenvironment and peripheral circulation of patients with cancer: implications for immunotherapyWHITESIDE, Theresa L.Vaccine. Supplement. 2002, Vol 20, pp A46-A51, issn 1359-5938, 4Conference Paper

Effect of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial), by Ling et alCROWE, Suzanne.AIDS (Supplement). 2003, Vol 17, pp S105-S107, issn 1350-2840, SUP4Article

Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG study A5047, by Fichtenbaum et alWANKE, Christine.AIDS (Supplement). 2003, Vol 17, pp S109-S110, issn 1350-2840, SUP4Article

A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy, by Cohen et alHIRSCHEL, Bernard.AIDS (Supplement). 2003, Vol 17, pp S114-S116, issn 1350-2840, SUP4Article

Study of bias in antenatal clinic HIV-1 surveillance data in a high contraceptive prevalence population in sub-Saharan Africa, by Gregson et alMASTRO, Timothy D.AIDS (Supplement). 2003, Vol 17, pp S122-S123, issn 1350-2840, SUP4Article

Effects of CCR5-Δ32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection, by Mulherin et alHOGG, Robert S.AIDS (Supplement). 2003, Vol 17, pp S127-S128, issn 1350-2840, SUP4Article

Plasticity of lymphoid compartments during HIV infection and treatments: hopes and limitsCOMBADIERE, Béhazine; CARCELAIN, Guislaine; DEBRE, Patrice et al.Microbes and infection. 2002, Vol 4, Num 5, pp 575-580, issn 1286-4579, 6 p.Article